Study of incidence of premature ovarian failure in patient attending outpatient department for infertility in a tertiary care centre

Authors

  • Qazi Jaweria Amber Department of Obstetrics and Gynecology, Grant Medical College and J. J. Group of Hospitals, Mumbai, Maharashtra, India
  • Tushar Tatyaba Palve Department of Obstetrics and Gynecology, Grant Medical College and J. J. Group of Hospitals, Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20194356

Keywords:

AMH low, High FSH, High LH, Infertility, Premature menopause, Premature ovarian failure, Secondary amenorrhoea

Abstract

Background: To assess the incidence of premature ovarian failure in cases attending infertility outpatient Department of Obstetrics and Gynecology in a tertiary care centre. A total of 350 patients attending infertility opd were screened over period of 150 days from which authors observed premature menopause in 10 cases accounting for an incidence of 2.8%. POF affects approximately one in 10,000 women by age 20; one in 1,000 women by age 30; one in 100 women by age 40.  Premature ovarian failure is a common cause of infertility in women.

Methods: Patient attending outpatient Department of Obstetrics and Gynecology with age less than 40 years and infertility, symptoms of menopause were enrolled for the study for duration of 150 days.

Results: Present study authors found a total of 2.8% of patient presenting in our outpatient department for infertility had Premature ovarian failure.80% of them were symptomatic suffering with symptoms of hormonal deficiencies .100% of patient with infertility diagnosed as premature ovarian failure had low AMH and High FSH and LH levels indicating poor prognosis.

Conclusions: Patient presenting with infertility and amenorrhoea can be cases of premature menopause. Here it is essential to investigate and treat the patient. Infertility might be one of the early presenting symptoms if not the first one. These patients if treated and diagnosed early can have a better living. Considering the wide spectrum of functional derangements in patient with early menopause and benefits of early hormone replacements these patients should be diagnosed and treated early.

References

Santoro N. Mechanism of premature ovarian failure. Ann Endocrinol. 2003;64:87-92.

Timmreck RR. Contemporary issues in primary amenorrhea. Obs Gynecol Clin North Am. 2003;30:278-302.

Coulam CB, Adamson AJ. Incidence of premature ovarian failure. Obs Gynecol. 1986;67:604-6.

Conway GS, Kaltsas G, Patel A, Davies MC JH. Characterization of idiopathic premature ovarian failure. Fertil Steril. 1996;(64):337-41.

Cramer DW, Xu H HB. Family history as a predictor of early menopause. Fertil Steril. 1995;(64):740-5.

Torgerson DJ, Thomas RD. Mothers and daughters menopausal ages: is there a link? Eur J Obs Gynecol. 1997;74:63-6.

Simpson RA. Ovarian differentiation and gonadal failure. Am J Med Genet. 1999;(89):186-200.

SL S. Premature ovarian failure in the fragile X syndrome. Am J Med Genet. 2000;97:189-94.

Achermann JC, Ozisik G, Meeks JJ JJ. Perspective: genetic causes of human reproductive diseases. Clin Endocrinol Metab. 2002;(87):2447-54.

Aittomaki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hyperonadotropic ovarian failure. Cell. 1995;(82):959-568.

Di Pasquale E, Beck-Peccoz PL. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum. Genet. 2004;(75):106-11.

Meduri G, Touraine P, Beau I, Lahuna O, Desroches A, Vacher-Lavenu MC. Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological, and molecular studies. Clin Endocrinol Metab. 2003;88:3491-8.

Z. B. Fertility treatment in women with premature ovarian failure. Expert Rev Obs Gynecol. 2011;6(3):321-30.

Nelson LM, Anasti JN, Kimzey LM. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab. 1994;79(5):1470-5.

RW R. Premature ovarian failure. 2009. Obs Gynecol. 2009;113(6):1355-63.

Webber L, Davies M. European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI, ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;31(5):926-37.

Van Kasteren SJ. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Updat. 1999;5(5):483-92.

Bukovsky A. Novel methods of treating ovarian infertility in older and POF women, testicular infertility, and other human functional diseases. Reprod Biol Endocrinol. 2015;25(13):10.

Baheti S, Verma A, Sharma M. Premature ovarian failure incidence, risk factors and its relation to BMI and infertility. Int J Reprod Contracept Obstet Gynecol. 2019;8:947-50.

Downloads

Published

2019-09-26

Issue

Section

Original Research Articles